APLS
Price
$19.10
Change
+$0.59 (+3.19%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
2.4B
67 days until earnings call
EYEN
Price
$3.13
Change
+$1.05 (+50.48%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
9.04M
Interact to see
Advertisement

APLS vs EYEN

Header iconAPLS vs EYEN Comparison
Open Charts APLS vs EYENBanner chart's image
Apellis Pharmaceuticals
Price$19.10
Change+$0.59 (+3.19%)
Volume$57.55K
Capitalization2.4B
Eyenovia
Price$3.13
Change+$1.05 (+50.48%)
Volume$14.75K
Capitalization9.04M
APLS vs EYEN Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. EYEN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and EYEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (APLS: $18.51 vs. EYEN: $2.08)
Brand notoriety: APLS and EYEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 47% vs. EYEN: 68%
Market capitalization -- APLS: $2.33B vs. EYEN: $6M
APLS [@Biotechnology] is valued at $2.33B. EYEN’s [@Biotechnology] market capitalization is $6M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileEYEN’s FA Score has 1 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • EYEN’s FA Score: 1 green, 4 red.
According to our system of comparison, EYEN is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while EYEN’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 4 bearish.
  • EYEN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EYEN is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а +10.18% price change this week, while EYEN (@Biotechnology) price change was +34.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

APLS is expected to report earnings on Aug 11, 2025.

EYEN is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($2.4B) has a higher market cap than EYEN($9.04M). APLS YTD gains are higher at: -41.993 vs. EYEN (-82.192). EYEN has higher annual earnings (EBITDA): -34.09M vs. APLS (-176.08M). APLS has more cash in the bank: 358M vs. EYEN (26.7M). EYEN has less debt than APLS: EYEN (13M) vs APLS (470M). APLS has higher revenues than EYEN: APLS (776M) vs EYEN (31.8K).
APLSEYENAPLS / EYEN
Capitalization2.4B9.04M26,566%
EBITDA-176.08M-34.09M517%
Gain YTD-41.993-82.19251%
P/E RatioN/AN/A-
Revenue776M31.8K2,440,252%
Total Cash358M26.7M1,341%
Total Debt470M13M3,615%
FUNDAMENTALS RATINGS
APLS vs EYEN: Fundamental Ratings
APLS
EYEN
OUTLOOK RATING
1..100
5434
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
8941
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYEN's Valuation (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for APLS (72) in the Medical Distributors industry. This means that EYEN’s stock grew somewhat faster than APLS’s over the last 12 months.

EYEN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as APLS (100) in the Medical Distributors industry. This means that EYEN’s stock grew similarly to APLS’s over the last 12 months.

APLS's SMR Rating (95) in the Medical Distributors industry is in the same range as EYEN (98) in the Pharmaceuticals Major industry. This means that APLS’s stock grew similarly to EYEN’s over the last 12 months.

EYEN's Price Growth Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for APLS (89) in the Medical Distributors industry. This means that EYEN’s stock grew somewhat faster than APLS’s over the last 12 months.

EYEN's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as APLS (100) in the Medical Distributors industry. This means that EYEN’s stock grew similarly to APLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLSEYEN
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFMGX37.140.14
+0.38%
DF Dent Midcap Growth Institutional
HHCCX14.29N/A
N/A
NexPoint Event Driven C
VCNIX23.40N/A
N/A
VALIC Company I NASDAQ-100 Index
MGGIX39.08N/A
N/A
Morgan Stanley Inst Global Opp I
VTWAX44.08N/A
N/A
Vanguard Total World Stock Index Admiral

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ROIV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-1.65%
ROIV - APLS
46%
Loosely correlated
-0.31%
BPMC - APLS
45%
Loosely correlated
+0.24%
EYPT - APLS
43%
Loosely correlated
+0.99%
DNLI - APLS
43%
Loosely correlated
+3.52%
BEAM - APLS
42%
Loosely correlated
+1.60%
More

EYEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYEN has been loosely correlated with CTXR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if EYEN jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYEN
1D Price
Change %
EYEN100%
-1.42%
CTXR - EYEN
47%
Loosely correlated
+1.04%
APM - EYEN
35%
Loosely correlated
+14.98%
VACBF - EYEN
32%
Poorly correlated
N/A
MRVI - EYEN
28%
Poorly correlated
-0.45%
INO - EYEN
28%
Poorly correlated
+2.36%
More